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Leukocytes must interact with vascular endothelial cells to be able to migrate
from the circulation to sites of inflammation. These cellular adhesion reactions
are mediated, in part, by surface molecules thatbelong to afamily ofstructurally
related glycoproteins: Mac-1, p150,95, and lymphocyte function-associated an-
tigen I (LFA-1)' (1). These proteins are composed of noncovalently linked a/o
heterodimers that have distinct a subunits with Mr of 170,000 (Mac-1, CD1 Ib),
150,000 (pl50,95, CDllc), and 180,000 (LFA-1, CDlla). The ,Q subunit
(CD18), Mr 95,000, has been shown to be identical in all three proteins by
physicochemical, immunochemical, and protein sequencing studies, and homol-
ogous to several adhesion receptors in other cell types (2, 3). The importance of
this family of surface proteins in leukocyte function is underscored by the
existence of a human genetic disease termed leukocyte adhesion deficiency
(LAD). Patients with LAD are deficient in expression ofall ofthese proteins and
suffer from recurrent life-threatening bacterial infections because their leuko-
cytes do not adhere to and migrate between endothelial cells to form an acute
inflammatory exudate (1).
While LFA-1 appears on the cell surface very early in the maturation of
neutrophils and monocytes, Mac-I and p150,95 are found on more mature cells
(4-6). In addition to being present on the plasma membrane, two of the
glycoproteins, Mac-1 and p150,95, are stored in a latent intracellular pool in
neutrophils and monocytes (7-11). Chemoattractants such as FMLP or phorbol
esters trigger a rapid 5-10-fold increase in Mac-1 and p150,95 expression on
the granulocyte cell surface. Because inhibitors ofprotein synthesis did not block
this increase, it seemed to represent mobilization to the surface ofa preexisting
intracellular pool. However, these chemoattractants do not induce LFA-1 on
granulocytes.
In the present study, we used immunocytochemical techniques on frozen thin
sections of human leukocytes to determine the subcellular location of the Mac-
1, p150,95, and LFA-1 leukocyte adhesion receptors (LAR). This method has
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the advantage that all organelle compartments are accessible to antibody without
the addition of permeabilizing agents that are deleterious to organelle structure,
as seen by high resolution microscopy. Using this method, we have been able to
demonstrate a latent pool of Mac- I and p150,95 in the membranes ofneutrophil-
specific granules.
Materials and Methods
Preparation of Antiserum.
￿
p150,95 was purified, and an antiserum to p150,95 was
prepared as previously described (12, 13). Briefly, a lysate of hairy cell leukemia spleen
cells was passed through a SHCL3 (anti-p150,95 mAb) immunoaffinity column. p150,95
was eluted at low pH, and 600 pmol were injected into a rabbit. After three boosts the
rabbit was bled and serum was collected.
Purification of Antiserum by Absorption Steps.
￿
To preclude reactivity with any cyto-
plasmic antigens contaminating the p150,95 antigen preparation, the antiserum was
absorbed with homogenized leukocytes from a patient severely deficient in Mac-1, LFA-
1, and p150,95 . The antiserum contained antibodies to both the p150,95 a subunit, and
the 0 subunit common to p150,95, Mac-1, and LFA-1, and it therefore was capable of
detecting all three glycoproteins (13). We, therefore, refer to the antigens detected by
these antibodies as leukocyte adhesion receptors (LAR).
Preparation of Human Leukocytes.
￿
Normal human leukocytes, anticoagulated in hepa-
rin, were sedimented in dextran and washed in HBSS. The cells were fixed in 0.25%
glutaraldehyde in 0.1 M phosphate buffer (pH 7.4) for 1 h at 4°C and were washed well
in the same buffer containing 5% (wt/vol) sucrose. They were then incubated for
peroxidase (14) to mark the peroxidase-positive azurophil granules (15). In other experi-
ments, 106 cells were incubated with 50 ng PMA for 15 min at 37°C before fixation in
order to cause degranulation .
Immunocylochemical Techniques on Frozen Thin Sections.
￿
The cell pellet was embedded
in 2.1 M sucrose, frozen, and stored in liquid nitrogen. Sections were cut on a Reichert-
Jung (Buffalo, NY) Ultracut E. The techniques used for preparing frozen thin sections
have been previously described (16). The primary antibody was used at a 1 :20 dilution.
The 5-nm immunogold probe goat anti-rabbit Ig-gold (GAR-5) was used at a 1 :50
dilution; the probes protein A-5 and A-10 were used at 1 :20-50 dilution (Janssen
Pharmaceutica, Beerse, Belgium). Nonimmune purified rabbit IgG was used as a control.
A double-labeling experiment to localize LAR and lactoferrin was performed using
protein A, as described by Slot and Geuze (17). Rabbit antibody against lactoferrin
(Accurate Chemical Co., Westbury, NY) was applied and labeled with protein A-10 .
Before the secondary antibody was applied, free protein A (0.05 mg/ml) was applied.
Subsequently, antibodies to LAR were applied, followed by protein A-5. Sections were
also labeled in reverse, using the large gold to label LAR and the small gold to label
lactoferrin. The grids were then stained with uranyl acetate and embedded in methylcel-
lulose as described by Tokuyasu (18) and modified by Griffiths (19).
The different secondary colloidal gold reagents were chosen because antibody-gold
complex (GAR-5) stains in clumps, whereas the protein A-golds stain in a 1 :1 ratio with
the primary antibody. Protein A therefore gives the most precise localization, whereas
GAR-5 is easier to detect because there are more grains per antibody site.
Results
Localization of LAR.
￿
Our goal was to investigate the distribution of LAR
within the organelles of resting polymorphonuclear neutrophillic leukocytes
(PMN). We used a polyclonal antiserum to the p150,95 a/# complex because it
was -much more reactive than mAb to Mac-1 or p150,95 in our immunolocali-
zation protocol. Immunoprecipitation showed that this antiserum crossreacted
with Mac-1, p150,95, and LFA-1, since it recognizes the common 0 subunit (13).BAINTON ET AL.
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Therefore, we designated it as an antibody to LAR. First, fixed leukocytes were
incubated for peroxidase to mark one of the major granule populations, the
azurophil (primary) granules (15). Frozen thin sections were then prepared and
incubated with the antiserum and immunogold. Sections incubated with polyclo-
nal antibody against LAR showed immunogold label along the membranes of
^-80% ofthe peroxidase-negative specific granules (Fig. 1). Less abundant label
was also seen on the plasma membrane (Fig. 1 a), the perinuclear cisterna (Fig.
1 c), and occasional small vesicles and multivesicular bodies (not illustrated).
When thepreliminary incubation for peroxidasewasomitted, sothatthecontents
ofazurophil granules would appear lucent and any immunogold label could be
more easily seen, no label for LAR was present on azurophil granules (not
illustrated). Negligible gold labeling was found when the primary antiserum was
replaced by normal rabbit serum.
Double-labeling ofLAR and Lactoferrin.
￿
Because lactoferrin has been used in
cell fractionation (20, 21) and immunocytochemical (22) studies to mark the
specific (secondary) granules, we wished to determine whether the granules
containing LAR also contained lactoferrin. Initially, thin sections were tested
with antibody to lactoferrin alone and immunolabeled with a large gold probe,
Protein A-10. Label for lactoferrin was present in the matrix of 80-90% of the
peroxidase-negative specific granules (Fig. 2a). When the cells were double-
labeled, using Protein A10 to label lactoferrin antibody and Protein A-5 to label
antibody to LAR, the larger gold label for lactoferrin was present in the matrix
ofthe specific granules, and the smaller gold-label for LAR was present along
the membrane of these granules (Fig. 2 b). The secondary gold labels were also
reversed, so that the small gold labeled LAR and the large gold labeled lactofer-
rin, with similar results (Fig. 2c).
Effect of PMA Stimulation on the Localization of LAR.
￿
Cells stimulated with
PMA before being immunolabeled for LAR (Fig. 3) showed vacuole formation
and degranulation. The heavy immunogold labeling ofthe plasma membrane is
consistent with the previous observation that PMA stimulation causes exocytosis
of specific granules and increased cell surface expression of the Mac-1 and
p150,95 LAR in neutrophils (7-11). Some ofthe vacuoles were also labeled, but
more sparsely than the plasma membrane. Although there is great variation of
labeling from cell to cell, counts ofgrains ofgold indicated a 10-fold increase in
plasma membrane density, over the resting cell. Note that most of the gold
particlesare on the exterior ofthe plasma membrane,whereas in specific granules
(Fig. 1), most of the gold particles are located on the interior of the granule
membrane.
Localization ofLAR in Other Leukocytes.
￿
In eosinophils, label was present along
the plasma membrane and was occasionally present in small intracellular vesicles
(Fig. 4). No label was detected in eosinophil granules. In basophils, there was
label on the plasma membrane, anda small amount in some intracellular granules
(Fig. 5).
In monocytes, label for LAR was present on the plasma membrane and in
peroxidase-negative granules and vesicles (9). Lymphocytes were labeled on the
plasma membrane only, whereas platelets were negative (not illustrated).FtcURE 1 .
￿
Electron micrographs of human neutrophils stained for peroxidase, incubated
with rabbit polyclonal antibody to LAR on a frozen thin section, and labeled with GAR-5.
The peroxidase-positive azurophil granules (ag) contain dense reaction product, whereas the
lighter, specific granules are peroxidase-negative . Most of the gold grains outline the mem-
branes of the specific granules (large arrows), although some are present in the matrix of these
granules. Because GAR-5 labels in clumps of two to six particles, label for an antibody site on
the membrane mayappear both on the membrane and in the matrix . Some of the peroxidase-
negative granules are not labeled (*) . Sonic label is present on the plasma membrane (pm) (a)
and in theperinuclear cisterna (pc) (c), and possibly other organelles (small arrow) (N, nucleus) .
Buffy-coat cells fixed in 0.25% glutaraldehyde for I h cold at VC, stainedforperoxidase, and
embedded in sucrose . (a) X 70,000 ; (b) X 75,000 ; (c) X 56,000 .
1644FIGURE 2.
￿
(a) Portion of a polymorphonuclear neutrophillic leukocyte (PMN) stained for
peroxidase to mark the azurophil granules (ag), then immunolabeled for lactoferrin . Many of
the peroxidase-negative specific granules have gold label within their matrix (arrows), but,
several contain no label (*) . The few grains of gold that are not within definite organelles
might represent grazing sections of granules in another plane of section . X 54,000 . (b) PMN
double-labeled for lactoferrin andLAR . Peroxidase-negative granules contain the large gold
label for lactoferrin within their matrices andthe small gold label for LARon theirmembranes
(arrowheads) . x 69,000 . (c) PMN double-labeled for LARand lactoferrin . Peroxidase-negative
granules contain the small gold label for lactoferrin within their matrices and the large gold
label for LAR on their membranes (arrowheads) . X 69,000 .1646
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FIGURE 3 .
￿
Polymorphonuclear neutrophillic leukocytes stimulated with PMAand then fixed
and immunolabeled for LAR as in Fig . 1 . After PMA stimulation, which causes partial
degranulation and the formation of many large intracellular vacuoles, immunolabel for LAR
is markedly greater than on the plasma membrane (pm) of the resting cell in Fig. Ia . Label is
also present (arrows) in some of the vacuoles (V' and V2) and in the perinuclear cisterna (pc) .
These cells were not incubated for peroxidase . x 35,000 .BAINTON ET AL .
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FIGURE 4.
￿
Portion of an eosinophil stained for peroxidase and then immunolabeled for
LAR. Heavy labeling of the plasma membrane (pm) canbe seen as well as label in small vesicles
(ve). The characteristic crystalline granules of the eosinophil are very dense with peroxidase
reaction product . Even in specimens not reacted for peroxidase (inset), no gold label was
detected in eosinophil granules . X 58,000 ; inset, X 44,000 .
Discussion
We have used a rabbit polyclonal antiserum raised against p150,95 to dem-
onstrate that an intracellular pool of LAR resides in the peroxidase-negative
specific granules of neutrophils . Because the antiserum recognizes both the a
and the ,B subunits of p150,95, and since Mac-1 and LFA-1 have the same S
subunit as p150,95, the antibody might have labeled the intracellular pools of
these adhesion proteins as well . Stimulated mobilization to the cell surface of
these proteins suggests that the latent pool in neutrophils contains more Mac-1
than p150,95, and little or no LFA-1, and thus, Mac-1 may have been the major
intracellular LAR labeled in these studies . The present data are sufficient to
state that the intracellular pool of the family of leukocyte adhesion proteins is
found mainly in peroxidase-negative specific granules, and that LAR expression
on the plasma membrane is increased afterPMA stimulation . These findings are
consistent with previous subcellular fractionation studies showing cosedimenta-1648
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FIGURE 5 .
￿
Portion of a basophilic granulocyte reacted for peroxidase and immunolabeled
for LAR. Note the heavy label on the plasma membrane (pm) as well as in some partially
extracted basophil granules (arrows). N, nucleus, m, mitochondria .x 45,000.
tion of Mac-1 (Mo 1) with vitamin BIZ-binding proteins, a specific granule marker
(8) . The detection of LAR on eosinophil and basophil plasma membranes has
not been previously described, and deserves further investigation .
Leukocyte adhesion receptors are transmembrane glycoproteins . The p150,95
a and j3 subunits have extracellular domains of 1,081 and 677 amino acids, andBAINTON ET AL.
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much smaller cytoplasmic domains of30 and 46 amino acids, respectively (2, 23,
24). Most GAR-5 staining ofthe plasma membrane was localized to the exterior,
and thus the antibody labels predominantly the extracellular domain. GAR-5
staining of peroxidase-negative granules was localized on the interior of the
surrounding membrane. This suggests that the extracellular domain of LAR is
orientedtothe interioroftheperoxidase-negativegranules. Fusion ofthe granule
membrane with the plasma membrane during exocytosis would result in expres-
sion on the exterior surface ofthe plasma membrane.
Thus far we have considered only the two major populations of granules in
neutrophils, the peroxidase-positive azurophil (or primary) granules, and the
peroxidase-negative specific (or secondary) granules. There may well be subpop-
ulations of chemically distinct granules within the populations of primary and
secondary granules, as broadly defined by cytochemical methods (25). In 1982,
investigators detected a gelatinase-containing organelle in neutrophils that se-
cretes its contents without secreting 11 12 binding proteins or other markers of
specific granules (26). A recent study suggested that 50% of intracellular Mo-1
(Mac-1) is localized in these labile, gelatinase-containing organelles (27). Another
recently defined granule that contains latent alkaline phosphatasehas been shown
to be readily mobilized to the cell surface by concentrations of FMLP that
stimulate increased Mac-I and p150,95 surface expression (28). More work is
necessary to clarify the relationship ofthese different organelles to the peroxi-
dase-negative granules studied here. In work with Dr. Margaret Hibbs (29) using
an affinity-purifiedantibody to gelatinase, we have colocalized gelatinase-positive
granules within a population of lactoferrin-positive granules. It would be helpful
if more attention were paid to lactoferrin in cell fractionation studies, so that the
results obtained by cell fractionation could be better integrated with those
obtained by immunocytochemical techniques. Unfortunately, there are not yet
any antibody probes for the B12-binding proteins. It should be noted that, when
demonstrated by immunocytochemical techniques, lactoferrin is present in only
80-90% of specific granules. It is not clear whether this reflects a limitation in
the method of detection or an absence of lactoferrin in some granules. We
found, similarly, that not all of the specific granules were labeled for LAR, but
it was clear in the double-labeling experiment that most specific granules con-
tained both.
The present studies, together with work on the extracellular matrix receptors
such as the fibronectin receptor and platelet GPIIb-IIIa, which are structurally
homologous to LAR (3), suggest several distinct mechanisms for regulating
adhesiveness during differentiation and activation of hematopoietic cells. Our
findings and the previous localization of Mac-1 by others (8, 30) suggest that
Mac-I and p150,95 are synthesized during the myelocyte stage of maturation,
since that is when specific granules are formed (15). As already discussed, small
amounts ofMac-1 and p150,95 are present on the plasma membranes ofmature
circulating PMN and monocytes. Chemoattractant agents can cause a significant
upregulation of these proteins, i.e., stimulate partial mobilization to the cell
surface of their intracellular granular pools, facilitating adherence of these
leukocytes to endothelial cells and subsequent migration to sites of local inflam-
mation (1). Qualitative changes, in addition to quantitative changes, may be1650
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important in regulating adhesive function in LAR expression (31). On the other
hand, the fibronectin receptor appears, and is functional, early in erythroid
maturation: cells from proerythroblasts through reticulocytes bind to fibronectin-
coated surfaces (32). Upon entering the circulation, reticulocytes quickly lose
this receptor because of events occurring in the spleen, and mature circulating
red bloodcellsdo not bind tofibronectin-coated surfaces (33). Finally, GPIIbIIIa,
the adhesion receptor on platelets that binds fibrinogen, fibronectin, and von
Willebrand's factor, does not function through downregulation or upregulation.
This receptor appears very early in maturation on committed stem cells (34), is
present at all stages of megakaryocyte development, and is present on platelets
that are circulating in the presence of its ligands. It binds its ligands only after
platelet activation with an agonist such as ADP or thrombin, which presumably
causes conformational change in the receptor (35). As more adhesion molecules
ofthis supergene family ofadhesion proteins (3) and their ligands are discovered,
it should be interesting to see whether they conform to the model of down-
regulation or disappearance of a functionally important receptor, upregulation
from an intracellular pool allowing adhesion, activation causing the receptor to
become competent to bind its ligand, or combinations of these models.
Summary
Previous studies have suggested that the leukocyte adhesion proteins Mac-1
and p150,95 are stored in a latent intracellular pool in neutrophils, and cellular
fractionation studies have shown that Mac-1 is localized primarily in the peroxi-
dase-negative specific granules. To determine the subcellular location of leuko-
cyte adhesion receptors (LAR), we used immunocytochemical techniques on
frozen thin sections of human blood leukocytes that had been incubated for
peroxidase to mark the peroxidase-positive azurophil granules. To enhance the
sensitivity of detection, polyclonal antibodies against immunoaffinity-purified
p150,95 were raised in rabbits and absorbed with leukocytes from a patient
deficient in this protein. The antiserum reacted with p150,95 and two other
antigens with the same /3 subunit, Mac-1 and lymphocyte function-associated
antigen 1 (LFA-1). In neutrophils, we observed immunogold label for LAR
predominantly on the membranesofperoxidase-negative granules, and in smaller
amounts on the plasma andperinuclearmembranes. In double-label experiments,
there was colocalization of LAR with lactoferrin in some of the peroxidase-
negative granules. We conclude that the latent pool of LAR resides in the
membranes of peroxidase-negative granules. A significant increase in label on
the plasma membrane of neutrophils stimulated with PMA is consistent with
secretion of LAR to the exterior ofthe cell during degranulation. While LFA-1
appears very early in neutrophil maturation, it is becoming clear that Mac-1 and
p150,95 are upregulated from an intracellular storage pool of peroxidase-
negative granules that appear during the myelocyte stage of differentiation.
Further studies are indicated to determine the significance of these proteins on
the plasma membrane of two other granulocytes, eosinophils and basophils.We thank Ms . MerleJolson and Ms . Barbara Poetter for preparation of the manuscript .
We are grateful for the professional assistance of Ms . Yvonne Jacques .
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